These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11331029)

  • 21. Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone.
    Vuoristo-Myllys S; Lahti J; Alho H; Julkunen J
    J Stud Alcohol Drugs; 2013 Nov; 74(6):894-901. PubMed ID: 24172116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of substance abuse treatment retention among women and men in an HMO.
    Mertens JR; Weisner CM
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1525-33. PubMed ID: 11045861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with receipt of behavioral health services among persons with substance dependence.
    Green-Hennessy S
    Psychiatr Serv; 2002 Dec; 53(12):1592-8. PubMed ID: 12461221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment variables that predict completion of an adolescent substance abuse treatment program.
    Blood L; Cornwall A
    J Nerv Ment Dis; 1994 Jan; 182(1):14-9. PubMed ID: 8277295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation.
    Ball SA; Carroll KM; Canning-Ball M; Rounsaville BJ
    Addict Behav; 2006 Feb; 31(2):320-30. PubMed ID: 15964152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting incentives to change among adolescents with substance abuse disorder.
    Breda C; Heflinger CA
    Am J Drug Alcohol Abuse; 2004 May; 30(2):251-67. PubMed ID: 15230075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinician-delivered contingency management increases engagement and attendance in drug and alcohol treatment.
    Fitzsimons H; Tuten M; Borsuk C; Lookatch S; Hanks L
    Drug Alcohol Depend; 2015 Jul; 152():62-7. PubMed ID: 25982007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuity of care practices and substance use disorder patients' engagement in continuing care.
    Schaefer JA; Ingudomnukul E; Harris AH; Cronkite RC
    Med Care; 2005 Dec; 43(12):1234-41. PubMed ID: 16299435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors that predict adolescent motivation for substance abuse treatment.
    Battjes RJ; Gordon MS; O'Grady KE; Kinlock TW; Carswell MA
    J Subst Abuse Treat; 2003 Apr; 24(3):221-32. PubMed ID: 12810143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment dropout as a function of treatment delay and client variables.
    Festinger DS; Lamb RJ; Kountz MR; Kirby KC; Marlowe D
    Addict Behav; 1995; 20(1):111-5. PubMed ID: 7785476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences by Gender in Predictors of Motivation Among Substance Abuse Treatment Participants.
    Taylor LR; Caudy M; Blasko BL; Taxman FS
    Subst Use Misuse; 2017 Mar; 52(4):468-476. PubMed ID: 28001464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug abuse treatment retention and process effects on follow-up outcomes.
    Simpson DD; Joe GW; Rowan-Szal GA
    Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of pre-treatment drop-out among persons with marijuana dependence.
    Vendetti J; McRee B; Miller M; Christiansen K; Herrell J;
    Addiction; 2002 Dec; 97 Suppl 1():125-34. PubMed ID: 12460134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hasin DS; Stinson FS; Ogburn E; Grant BF
    Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking stage of change is associated with retention in a smoke-free residential drug treatment program for women.
    Haller DL; Miles DR; Cropsey KL
    Addict Behav; 2004 Aug; 29(6):1265-70. PubMed ID: 15236833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients.
    O'Toole TP; Strain EC; Wand G; McCaul ME; Barnhart M
    J Gen Intern Med; 2002 May; 17(5):334-40. PubMed ID: 12047729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Post-Treatment Employment for Individuals with Substance Use Disorders.
    Kim M; Leierer S; Jeon J
    Community Ment Health J; 2019 Oct; 55(7):1236-1245. PubMed ID: 31267298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment attrition from couple therapy for male drug abusers.
    Kelly S; Epstein EE; McCrady BS
    Am J Drug Alcohol Abuse; 2004; 30(1):1-19. PubMed ID: 15083551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.